David Brozyna
Psychiatry · Rutherford, NJNPI 1114042462
Payments from drug & device makers
Across 143 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$523
- Jazz Pharmaceuticals Inc.$468
- AbbVie$335
- Otsuka America Pharmaceutical, Inc.$270
- Axsome Therapeutics, Inc.$245
- Bausch Health US, LLC$220
- plus $626 from 14 others
What the payments were for
- Food & beverage$2,688100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $523 |
| Jazz Pharmaceuticals Inc. | 18 | $468 |
| AbbVie(2 entities) | 23 | $335 |
| Otsuka America Pharmaceutical, Inc. | 20 | $270 |
| Axsome Therapeutics, Inc. | 9 | $245 |
| Bausch Health US, LLC | 15 | $220 |
| Vanda Pharmaceuticals Inc. | 10 | $128 |
| Supernus Pharmaceuticals, Inc. | 5 | $69 |
| Neuronetics, Inc. | 2 | $59 |
| Vertical Pharmaceuticals, LLC | 4 | $58 |
| Arbor Pharmaceuticals, Inc. | 4 | $56 |
| Shire North American Group Inc | 3 | $45 |
| Neurocrine Biosciences, Inc. | 3 | $43 |
| Eisai Inc. | 3 | $42 |
| Tris Pharma Inc | 2 | $34 |
| Johnson & Johnson | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,688 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 15 | $6,354 |
| Lisdexamfetamine Dimesylate | 26 | $5,957 |
| VyvanseLisdexamfetamine Dimesylate | 15 | $5,477 |
| ConcertaMethylphenidate Hcl | 11 | $4,794 |
| PristiqDesvenlafaxine Succinate | 12 | $4,648 |
| Clozapine | 20 | $3,157 |
| Atomoxetine Hcl | 15 | $2,645 |
| Clonazepam | 163 | $2,209 |
| Dextroamphetamine Sulfate | 29 | $1,767 |
| Trazodone Hcl | 76 | $1,577 |
| RitalinMethylphenidate Hcl | 20 | $1,279 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 53 | $1,277 |
| Mirtazapine | 29 | $1,168 |
| Aripiprazole | 47 | $1,108 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $1,107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonConcerta | $27 | $4,79411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Rutherford
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.